KRT5 and carcinoma: Incorporation of additional markers such as Ki67 [56] or specific cytokeratin subtypes (i.e., CK5/6, CK7, and CK20) [57,58] could improve the identification of epithelial subpopulations and distinguish carcinoma cells more accurately from their normal counterparts.